Skip to content
ISMO

Choosing the right treatment pathway in pancreatic cancer

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference also heard a presentation from Prof Maeve Lowery, Consultant Medical...
Choosing the right treatment pathway in pancreatic cancer

Oncology community standing together, apart

Gathering Around Cancer, virtual meeting, 5-6 November 2020 This year’s Gathering Around Cancer 2020 conference was opened by Prof John...
Oncology community standing together, apart

Advances in lung cancer

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference heard from Dr Jarushka Naidoo, Consultant Medical Oncologist at Beaumont...
Advances in lung cancer

Breast cancer care in the Covid context

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The meeting also heard from Prof Seamus O’Reilly, National Director in Medical...
Breast cancer care in the Covid context

Chemotherapy and Covid-19 — assessing the outcomes

Gathering Around Cancer, virtual meeting, 5-6 November 2020 During the segment of Gathering Around Cancer 2020 dedicated to issues around...
Chemotherapy and Covid-19 — assessing the outcomes

Clinical perspectives on melanoma

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The Gathering Around Cancer conference also heard from Dr Fergal Kelleher, Consultant...
Clinical perspectives on melanoma

Research updates in kidney cancer

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference heard from Dr Jack Gleeson, Haematology Specialist in Memorial Sloan...
Research updates in kidney cancer

Burned in the USA — the high risk of burnout for US oncologists

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The Gathering Around Cancer 2020 conference heard a keynote address from Dr...
Burned in the USA — the high risk of burnout for US oncologists

Body and mind combined in cancer care

Gathering Around Cancer, virtual meeting, 5-6 November 2020 The meeting heard from Dr Helen Greally, National Clinical Lead in Psycho-Oncology...
Body and mind combined in cancer care

ASCO Annual Meeting 2019, Chicago, IL

Priscilla Lynch presents a round-up of the most important studies presented at the 2019 American Society of Clinical Oncology (ASCO)...
ASCO Annual Meeting 2019, Chicago, IL
Choosing the right treatment pathway in pancreatic cancer Choosing the right treatment pathway in pancreatic cancer
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference also heard a presentation from Prof Maeve Lowery, Consultant Medical...
Oncology community standing together, apart Oncology community standing together, apart
Gathering Around Cancer, virtual meeting, 5-6 November 2020 This year’s Gathering Around Cancer 2020 conference was opened by Prof John...
Advances in lung cancer Advances in lung cancer
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference heard from Dr Jarushka Naidoo, Consultant Medical Oncologist at Beaumont...
Breast cancer care in the Covid context Breast cancer care in the Covid context
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The meeting also heard from Prof Seamus O’Reilly, National Director in Medical...
Chemotherapy and Covid-19 — assessing the outcomes Chemotherapy and Covid-19 — assessing the outcomes
Gathering Around Cancer, virtual meeting, 5-6 November 2020 During the segment of Gathering Around Cancer 2020 dedicated to issues around...
Clinical perspectives on melanoma Clinical perspectives on melanoma
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The Gathering Around Cancer conference also heard from Dr Fergal Kelleher, Consultant...
Research updates in kidney cancer Research updates in kidney cancer
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The conference heard from Dr Jack Gleeson, Haematology Specialist in Memorial Sloan...
Burned in the USA — the high risk of burnout for US oncologists Burned in the USA — the high risk of burnout for US oncologists
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The Gathering Around Cancer 2020 conference heard a keynote address from Dr...
Body and mind combined in cancer care Body and mind combined in cancer care
Gathering Around Cancer, virtual meeting, 5-6 November 2020 The meeting heard from Dr Helen Greally, National Clinical Lead in Psycho-Oncology...
ASCO Annual Meeting 2019, Chicago, IL ASCO Annual Meeting 2019, Chicago, IL
Priscilla Lynch presents a round-up of the most important studies presented at the 2019 American Society of Clinical Oncology (ASCO)...

ASCO 2021 round-up

,

Priscilla Lynch presents a round-up of some of the most topical research presented at this year’s ASCO Annual Meeting ASCO rapid guideline update for HER2-negative breast cancer Anew American Society of Clinical Oncology (ASCO) guideline update recommends offering one year of adjuvant olaparib to patients with high-risk early-stage human epidermal growth factor receptor 2 (HER2)-negative…

Addition of immunotherapy to standard of care first-line regimen delays disease progression in advanced NPC

,

Priscilla Lynch presents a round-up of some of the most topical research presented at this year’s ASCO Annual Meeting The addition of the immunotherapy agent toripalimab to standard first-line chemotherapy significantly delayed disease progression for patients with recurrent or metastatic nasopharyngeal carcinoma (NPC), according to the findings of a phase 3 international study, presented at…

Both single and dual immunotherapy regimens offer improved overall survival for select patients with advanced oesophageal cancer

Priscilla Lynch presents a round-up of some of the most topical research presented at this year’s ASCO Annual Meeting Compared to standard of care chemotherapy, both a dual immunotherapy regimen and a single immunotherapy agent added to chemotherapy extends overall survival (OS) for patients with advanced oesophageal squamous cell carcinoma, particularly those positive for the…

Post-surgery immunotherapy extends disease-free survival for select patients with kidney cancer

Priscilla Lynch presents a round-up of some of the most topical research presented at this year’s ASCO Annual Meeting Immunotherapy after surgery significantly improved disease-free survival (DFS) for patients with the most common type of kidney cancer, clear-cell renal carcinoma (RCC). A phase 3 international study, presented at the 2021 ASCO Annual Meeting, found that…

Immunotherapy delays disease recurrence in patients with early-stage lung cancer

Priscilla Lynch presents a round-up of some of the most topical research presented at this year’s ASCO Annual Meeting Treatment with the immunotherapy checkpoint inhibitor atezolizumab extended disease-free survival (DFS) in patients with resected, early-stage non-small cell lung cancer (NSCLC), particularly those positive for the immune checkpoint protein PD-L1, according to new research presented at…

Additional chemotherapy does not offer survival benefit for patients with locally advanced cervical cancer

Priscilla Lynch presents a round-up of some of the most topical research presented at this year’s ASCO Annual Meeting Additional chemotherapy given after standard chemoradiation treatment does not improve survival for women with locally advanced cervical cancer, and is associated with additional side-effects, according to results of a phase 3 international trial presented at the…

The Gander – 14 November 2019

,
Scroll To Top